This inventor holds 1 USPTO granted patent. Top assignee: Yonsei University. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Jeon Soo Shin: Innovator in Nanoparticle Technology
Introduction
Jeon Soo Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of nanotechnology, particularly in the development of multifunctional nanoparticles. His innovative work has the potential to revolutionize drug delivery systems and disease treatment.
Latest Patents
Jeon Soo Shin holds a patent for "Multi-functional nanoparticles partially-deposited with gold film." This invention involves multifunctional nanoparticles that consist of polymer nanoparticles loaded with a drug, a gold thin film deposited on part of the surface, and an antibody conjugated to the gold film. The method for preparing these nanoparticles includes several steps, such as loading a drug into a polymer, depositing a gold thin film, and conjugating an antibody to the gold film. This technology not only enhances drug delivery but also offers a method for diagnosing and treating diseases.
Career Highlights
Jeon Soo Shin is affiliated with Yonsei University, where he conducts research and develops innovative technologies. His work has garnered attention in the scientific community, and he continues to push the boundaries of what is possible in nanoparticle applications.
Collaborations
He collaborates with notable colleagues, including Kyung Hwa Yoo and Seungjoo Haam, to advance research in this field. Their combined expertise contributes to the development of cutting-edge solutions in nanotechnology.
Conclusion
Jeon Soo Shin's contributions to the field of nanotechnology, particularly through his patented multifunctional nanoparticles, highlight his role as an innovator. His work at Yonsei University and collaborations with esteemed colleagues further emphasize the impact of his research on future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
